Elphogene Revenue

Biotechnology Research • Prague, Capital City of Prague, Czechia • 1-10 Employees

Elphogene revenue & valuation

Annual revenue	$598,885
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,000,000
Total funding	$500,000

Key Contact at Elphogene

Marek Minárik

Chief Executive Officer

Company overview

Headquarters	Drnovská, 1112/60, Praha 6, Hlavní město Praha 16100, CZ
Phone number	+42020112020
Website	elphogene.cz
Employees	1-10
Socials

Elphogene Email Formats

Elphogene uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@elphogene.cz), used 100% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@elphogene.cz	100%

About Elphogene

Pražský biotechnologický start-up Elphogene, s.r.o., který vznikl jako spin-off výzkumného ústavu Genomac v Praze, představil v roce 2019 projekt oncoMonitor™ pro sledování cirkulující nádorové DNA (označované jako ctDNA) u onkologických pacientů. oncoMonitor™ je nový, unikátní diagnostický test, který byl vyvinut v České republice na základě deset let trvajícího výzkumu a klinických studií ve spolupráci s předními českými onkologickými centry. Je založený na tzv. tekuté biopsii neboli vyšetření ctDNA v periferní krvi pacientů s pokročilým nádorovým onemocněním. Účelem testu oncoMonitor™ je dlouhodobé sledování pokročilého nádorového onemocnění pacientů pro časný záchyt případných nově vzniklých nádorových ložisek. Tato technologie je schopna zachytit ctDNA až u 88 % pacientů v pokročilém stádiu rakoviny tlustého střeva a konečníku s přítomnými metastázami v játrech. ------------------------------------------------------------------------------- A Prague-based biotechnological start-up Elphogene, s.r.o. which has been founded as a spin-off from the Genomac Research Institute introduced a project oncoMonitor™ for monitoring circulating tumor DNA (referred to as ctDNA) in cancer patients in 2019. oncoMonitor™ is a new diagnostic tool based on liquid biopsy – screening of ctDNA in peripheral blood of cancer patients. It was developed in the Czech Republic based on ten years of research and collaboration with leading oncology centers. The purpose of oncoMonitor™ is a follow-up of patients in advanced stages of cancer for early detection of newly arising metastatic lesions. The technology is capable of capturing ctDNA in up to 88% of patients with advanced colorectal cancer with the presence of liver metastases.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

C-Suite

Employees by Department

Elphogene has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Elphogene's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2019-05-05	2	$250,000
2020-05-01	3	$250,000

Funding Insights

$500,000

Total funding amount

$250,000

Most recent funding amount

Number of funding rounds

Elphogene Tech Stack

Discover the technologies and tools that power Elphogene's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

Lodash

JavaScript libraries

Sentry

Issue trackers

Wix

Blogs

HTTP/3

Miscellaneous

HSTS

Security

Open Graph

Miscellaneous

React

JavaScript frameworks

Google Cloud

IaaS

Google Cloud CDN

CDN

Priority Hints

Performance

Frequently asked questions

Elphogene is located in Prague, Capital City of Prague, CZ.

You can reach Elphogene at +42020112020.

Elphogene generates an estimated annual revenue of $598,885. This revenue figure reflects the company's market position and business performance in its industry.

Elphogene has an estimated valuation of $2,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Elphogene has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Elphogene has raised a total of $500,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Elphogene

Marek Minárik

Chief Executive Officer

4.8

40,000 users